Skip Navigation
Grant Details

Grant Number: 2R01CA046475-14 Interpret this number
Primary Investigator: Colditz, Graham
Organization: Brigham And Women'S Hosp., Inc.
Project Title: Benign Breast Disease and Risk of Breast Cancer
Fiscal Year: 2005
Back to top


Abstract

DESCRIPTION (provided by applicant): To understand the multi-factorial nature of breast carcinogenesis, we must determine what factors play a role at each stage. By studying benign breast disease we can examine an earlier period in the disease process. This proposal aims to examine a full spectrum of stages on the pathway to breast cancer in Nurses' Health Study I and II: 1) early stages by focusing on the relationship between adolescent diet and incidence of proliferative breast disease; 2) intermediate and cumulative lifetime exposures by concentrating on genetic and molecular predictors of proliferative breast disease; and 3) later stages by examining protein expression in benign breast tissue and subsequent breast cancer risk. Specifically, we hypothesize that adolescent intake of total and specific subtypes of fat are associated with proliferative breast disease; polymorphisms and haplotypes in the insulin-like growth factor (IGF)-I pathway and the progesterone receptor, as well as circulating levels of IGF-1 and IGFBP-3, are related to incidence of proliferative benign breast disease; expression of molecular markers (ER-a, PR, IGF-1 R, Ki67 and cytokeratin 5/6) in benign breast disease tissue is associated with subsequent risk of breast cancer. This study offers a unique opportunity to prospectively examine adolescent diet and molecular markers in relation to proliferative breast disease. Additional follow-up of the breast cancer nested case-control data set will allow us to examine in more detail the relationship between proliferative breast disease and subsequent breast cancer. The creation of tissue microarrays using benign breast tissue will lay the foundation for this and future studies to efficiently examine the role of molecular markers in the development of breast cancer.

Back to top


Publications

Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.
Authors: Grodstein F, Manson JE, Stampfer MJ, Rexrode K
Source: Arch Intern Med, 2008 Apr 28;168(8), p. 861-6.
PMID: 18443262
Related Citations

Back to top


High school dietary dairy intake and teenage acne.
Authors: Adebamowo CA, Spiegelman D, Danby FW, Frazier AL, Willett WC, Holmes MD
Source: J Am Acad Dermatol, 2005 Feb;52(2), p. 207-14.
PMID: 15692464
Related Citations

Back to top


Dietary flavonols and flavonol-rich foods intake and the risk of breast cancer.
Authors: Adebamowo CA, Cho E, Sampson L, Katan MB, Spiegelman D, Willett WC, Holmes MD
Source: Int J Cancer, 2005 Apr 20;114(4), p. 628-33.
PMID: 15609322
Related Citations

Back to top


A prospective study of folate intake and the risk of pancreatic cancer in men and women.
Authors: Skinner HG, Michaud DS, Giovannucci EL, Rimm EB, Stampfer MJ, Willett WC, Colditz GA, Fuchs CS
Source: Am J Epidemiol, 2004 Aug 1;160(3), p. 248-58.
PMID: 15257998
Related Citations

Back to top


Employment status, social ties, and caregivers' mental health.
Authors: Cannuscio CC, Colditz GA, Rimm EB, Berkman LF, Jones CP, Kawachi I
Source: Soc Sci Med, 2004 Apr;58(7), p. 1247-56.
PMID: 14759673
Related Citations

Back to top


Biopsy confirmed benign breast disease, postmenopausal use of exogenous female hormones, and breast carcinoma risk.
Authors: Byrne C, Connolly JL, Colditz GA, Schnitt SJ
Source: Cancer, 2000 Nov 15;89(10), p. 2046-52.
PMID: 11066044
Related Citations

Back to top


Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types.
Authors: Marshall LM, Hunter DJ, Connolly JL, Schnitt SJ, Byrne C, London SJ, Colditz GA
Source: Cancer Epidemiol Biomarkers Prev, 1997 May;6(5), p. 297-301.
PMID: 9149887
Related Citations

Back to top